Alpha 2.0
Login Register
» Articles » PMID: 32297445

Is "Geriatric" Assessment Just for Older Patients?

Overview
Journal Oncologist
Publisher Oxford University Press
Specialty Oncology
Date 2020 Apr 17
PMID 32297445
Citations 10
Authors
Gabriel F P Aleixo
Seul Ki Choi
Alyssa J Tan
Kirsten A Nyrop
Alyson M Deal
William A Wood
Trevor A Jolly
Hyman B Muss
Affiliations
Soon will be listed here.
Abstract

Geriatric assessment (GA) is used in oncology to identify deficits in older patients with cancer that may affect treatment choice. We examine GA in 550 patients with early breast cancer, including both younger (<65 years) and older women (aged 65 years or older), to assess the potential value of this tool in younger, presumed "healthier" patients. Although older women have more GA-identified deficits overall, younger patients are more anxious. Suboptimal physical function was problematic across the age spectrum. GA domains can identify major deficits in younger patients beyond those likely to be uncovered in routine investigation.

Citing Articles

Trajectories of physical well-being among adults with acute myeloid leukemia.

Jensen-Battaglia M, Sohn M, Consagra W, Wang Y, Zhang Z, LoCastro M Blood Adv. 2024; 8(11):2612-2621.

PMID: 38429079 PMC: 11157208. DOI: 10.1182/bloodadvances.2023011804.

Prognostic Effect of Performance Status on Outcomes of Patients with Colorectal Cancer Receiving First-Line Chemotherapy: A Meta-analysis.

Colloca G, Venturino A J Gastrointest Cancer. 2023; 55(1):418-426.

PMID: 37966630 DOI: 10.1007/s12029-023-00983-8.

Rural-urban disparities in mortality and geriatric assessment among older adults with cancer: The cancer & aging resilience evaluation (CARE) registry.

Fowler M, Kenzik K, Al-Obaidi M, Harmon C, Giri S, Arora S J Geriatr Oncol. 2023; 14(4):101505.

PMID: 37087962 PMC: 10207384. DOI: 10.1016/j.jgo.2023.101505.

Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years.

Lew M, Ren Y, Lowder Y, Siamakpour-Reihani S, Ramalingam S, Romero K Transplant Cell Ther. 2022; 28(8):498.e1-498.e9.

PMID: 35595226 PMC: 10042624. DOI: 10.1016/j.jtct.2022.05.018.

Use of Single-Item Self-Rated Health Measure to Identify Frailty and Geriatric Assessment-Identified Impairments Among Older Adults with Cancer.

Giri S, Mir N, Al-Obaidi M, Clark D, Kenzik K, McDonald A Oncologist. 2022; 27(1):e45-e52.

PMID: 35305105 PMC: 8842332. DOI: 10.1093/oncolo/oyab020.

References
1.
Guerard E, Deal A, Williams G, Jolly T, Nyrop K, Muss H . Falls in Older Adults With Cancer: Evaluation by Oncology Providers. J Oncol Pract. 2015; 11(6):470-4. PMC: 5706133. DOI: 10.1200/JOP.2014.003517. View
2.
Jolly T, Deal A, Nyrop K, Williams G, Pergolotti M, Wood W . Geriatric assessment-identified deficits in older cancer patients with normal performance status. Oncologist. 2015; 20(4):379-85. PMC: 4391761. DOI: 10.1634/theoncologist.2014-0247. View
3.
Guerard E, Deal A, Chang Y, Williams G, Nyrop K, Pergolotti M . Frailty Index Developed From a Cancer-Specific Geriatric Assessment and the Association With Mortality Among Older Adults With Cancer. J Natl Compr Canc Netw. 2017; 15(7):894-902. DOI: 10.6004/jnccn.2017.0122. View
4.
Hurria A . Geriatric assessment in oncology practice. J Am Geriatr Soc. 2010; 57 Suppl 2:S246-9. PMC: 3845875. DOI: 10.1111/j.1532-5415.2009.02503.x. View
5.
Basch E, Dueck A, Rogak L, Mitchell S, Minasian L, Denicoff A . Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048. J Clin Oncol. 2018; :JCO2018788620. PMC: 6209091. DOI: 10.1200/JCO.2018.78.8620. View